French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
作者信息
Hauchecorne J
机构信息
Service d'Oncologie Médicale, Hôpital de la Salpétrière, Paris.
出版信息
Prog Clin Biol Res. 1987;243B:229-34.
PMID:3309983
Abstract
摘要
相似文献
1
French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
Prog Clin Biol Res. 1987;243B:229-34.
2
Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
Prog Clin Biol Res. 1989;303:177-86.
3
Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
Can J Surg. 1983 Sep;26(5):434-8.
4
Randomised, double-blind study of estramustine phosphate and leuprolide acetate.
Prog Clin Biol Res. 1987;243B:227-8.
5
The EORTC Phase III trials in prostatic cancer.
Prog Clin Biol Res. 1985;185A:243-9.
6
[Plasma changes caused by estrogens in the vascular risk of prostatic carcinoma over a 3-year period].
Actas Urol Esp. 1986 Nov-Dec;10(6):437-40.
7
Estramustine for prostate cancer.
Med Lett Drugs Ther. 1982 Aug 6;24(615):74.
8
Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
Urology. 1984 Jun;23(6 Suppl):64-8. doi: 10.1016/s0090-4295(84)80101-6.
9
A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
Semin Oncol. 1983 Sep;10(3 Suppl 3):43-5.
10
Mode of action of estramustine phosphate in hormone dependent and hormone non-dependent prostate cancer.磷酸雌莫司汀在激素依赖性和激素非依赖性前列腺癌中的作用机制。
Prog Clin Biol Res. 1985;185A:197-202.
引用本文的文献
1
Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.磷酸雌莫司汀钠。对其药效学、药代动力学特性及在前列腺癌治疗中的疗效的综述。
Drugs Aging. 1995 Jul;7(1):49-74. doi: 10.2165/00002512-199507010-00006.
2
Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.
Int Urol Nephrol. 1989;21(4):393-7. doi: 10.1007/BF02559635.
Zotero 插件